| Product Name | : | Lapanix |
| Generic Name | : | Lapatinib |
| Formulation | : | Tablet |
| Available Pack Size | : | 150's Pot |
| Available Strength | : | 250 mg |
| Registrations | : | Export Only |
| Website | : | Lapanix.com |
-
Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines. Product Features: -
Product Description: Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. Product Features:Product Name : Axinix Generic Name : Axitinib Formulation : Tablet Available Pack Size : 180's Pot & 60's Po Available Strength : 1 mg & 5 mg Registrations : Export Only Website : Axinix.com -
Product Description: Tofacitinib is indicated for the treatment of adult patients withmoderately to severely active rheumatoid arthritis who have hadan inadequate response or intolerance to methotrexate. It may beused as monotherapy or in combination with methotrexate orother nonbiologic disease-modifying antirheumatic drugs(DMARDs). Product Features:Product Name : Tofacinix Generic Name : Tofacitinib Formulation : Tablet Available Pack Size : 3x10's Alu-Alu Available Strength : 11 mg Registrations : Export Only Website : Tofacinix.com -
Product Description: Favipira is the preparation of favipiravir. Favipira is a drug the use of which is considered only when there is an outbreak of novel or re-emerging influenza virus infections in which other anti-influenza virus agents are not effective or insufficiently effective, and the government decides to use the drug as a countermeasure against such influenza’s viruses. When administering the drug, obtain the latest information including government’s direction of countermeasures a gain such influenza viruses, and prescribe only to appropriate patients. In present situation Favipira is using to treat COVID-19 patients. This drug is showing hope for the COVID-19 patients. Product Features:Product Name : Favipira Generic Name : Favipiravir Formulation : Tablet Available Pack Size : 200 mg (Oral Tablet) Available Strength : 2 x 10’s Registrations : Bangladesh -
Product Description: Beacon Pharmaceuticals Limited (BPL) has launched Pandovir 100, a broad-spectrum antiviral medicine, for the treatment of severe Covid-19 cases under the generic of Remdesivir. Directorate General of Drug Administration (DGDA) considered it as an Emergency Use Authorization (EUA) for the patients who are hospitalized with probable or laboratory-confirmed case of SARS-CoV-2. The medicine will be available in the market in a single strength --100mg –injection with a new packaging availing the brand name Pandovir,that will open a new horizon for treating the severely ill Covid-19 patients. The Packaging includes 2 vial (1 vial of Remdisivir 100 mg Lyophilized powder & 1 vial of 20 mL WFI) and a leaflet. Product Features:Product Name : Pandovir Generic Name : Remdisivir Formulation : Injection Available Pack Size : 1’s Available Strength : 100 mg